Literature DB >> 10608754

Impact of the ovulatory cycle on virologic and immunologic markers in HIV-infected women.

R M Greenblatt1, N Ameli, R M Grant, P Bacchetti, R N Taylor.   

Abstract

An individual's sex influences plasma human immunodeficiency virus type 1 (HIV-1) RNA level and rate of CD4 cell decline, but the mechanism for this effect is currently unknown. To determine the effect of the ovulatory cycle on HIV-1 RNA level and lymphocyte subsets in HIV-infected women, blood specimens were obtained weekly from 14 women infected with HIV. Participants reported regular menses and were not using hormonal medications or narcotics. The occurrence of ovulation was verified by use of endocrine criteria. Ovulation occurred in 10 of the 14 women. Among women who ovulated, median HIV-1 RNA level fell by a median of 0.16 log10 from the early follicular phase to the midluteal phase (P=.03, Wilcoxon signed-rank test). When women who did not ovulate were included in the analysis, no significant fluctuation in plasma HIV RNA level was identified. Thus, the ovulatory cycle influenced circulating HIV-1 RNA levels, a finding that is plausible because of the known effect of sex hormones on lymphocyte function and cytokine production.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10608754     DOI: 10.1086/315207

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Hormonal markers of susceptibility to sexually transmitted infections: are we taking them seriously?

Authors:  L Brabin
Journal:  BMJ       Date:  2001-08-18

2.  17β-Estradiol inhibits HIV-1 by inducing a complex formation between β-catenin and estrogen receptor α on the HIV promoter to suppress HIV transcription.

Authors:  Erika L Szotek; Srinivas D Narasipura; Lena Al-Harthi
Journal:  Virology       Date:  2013-06-12       Impact factor: 3.616

3.  Effectiveness of highly active antiretroviral therapy among HIV-1 infected women.

Authors:  S J Gange; Y Barrón; R M Greenblatt; K Anastos; H Minkoff; M Young; A Kovacs; M Cohen; W A Meyer; A Muñoz
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

4.  Impact of Biological Sex on Immune Activation and Frequency of the Latent HIV Reservoir During Suppressive Antiretroviral Therapy.

Authors:  Shane D Falcinelli; Bonnie E Shook-Sa; Morgan G Dewey; Sumati Sridhar; Jenna Read; Jennifer Kirchherr; Katherine S James; Brigitte Allard; Simon Ghofrani; Erin Stuelke; Caroline Baker; Nadia R Roan; Joseph J Eron; JoAnn D Kuruc; Catalina Ramirez; Cynthia Gay; Katie R Mollan; David M Margolis; Adaora A Adimora; Nancie M Archin
Journal:  J Infect Dis       Date:  2020-11-09       Impact factor: 5.226

5.  An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy.

Authors:  John R Koethe; Cathy A Jenkins; Bryan E Shepherd; Samuel E Stinnette; Timothy R Sterling
Journal:  Clin Infect Dis       Date:  2011-09-26       Impact factor: 9.079

Review 6.  Sexual dimorphism in HIV-1 infection.

Authors:  Anne Rechtien; Marcus Altfeld
Journal:  Semin Immunopathol       Date:  2018-10-01       Impact factor: 9.623

Review 7.  Gynecologic issues in the HIV-infected woman.

Authors:  Helen E Cejtin
Journal:  Infect Dis Clin North Am       Date:  2008-12       Impact factor: 5.982

Review 8.  Gonadal function and reproductive health in women with human immunodeficiency virus infection.

Authors:  Swaytha Yalamanchi; Adrian Dobs; Ruth M Greenblatt
Journal:  Endocrinol Metab Clin North Am       Date:  2014-09       Impact factor: 4.741

Review 9.  Sex differences in HIV-1-mediated immunopathology.

Authors:  Susanne Ziegler; Marcus Altfeld
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

10.  The Association Between HIV Status, Estradiol, and Sex Hormone Binding Globulin Among Premenopausal Women in the Women's Interagency HIV Study.

Authors:  Sally B Coburn; Jodie Dionne-Odom; Maria L Alcaide; Caitlin A Moran; Lisa Rahangdale; Elizabeth T Golub; Leslie Stewart Massad; Dominika Seidman; Katherine G Michel; Howard Minkoff; Kerry Murphy; Todd T Brown; Kala Visvanathan; Bryan Lau; Keri N Althoff
Journal:  J Womens Health (Larchmt)       Date:  2022-01-17       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.